Share on Facebook Share on Twitter Email
Answers.com

XOMA Ltd.

 
(NASDAQ:XOMA)
Contact Information
XOMA Ltd.
2910 7th St.
Berkeley, CA 94710
CA Tel. 510-204-7200
Toll Free 800-246-9662
Fax 510-644-0537

Type: Public
On the web: http://www.xoma.com
Employees: 230
Employee growth: 17.9%

XOMA doesn't want to toil in anonymity. Instead, the company pairs with larger drug firms to develop and market its products, primarily monoclonal antibodies (biotech drugs based on cloned proteins). The firm partners on therapeutics for cancer, infectious disease, inflammatory ailments, and autoimmune conditions; it also receives royalties on drugs developed by companies that have licensed its technologies. XOMA has collaborative agreements with companies and entities such as Takeda Pharmaceutical, Merck, and the National Institutes of Health (to find treatments for bioterrorism threat botulinum). In addition, the company has some proprietary candidates for metabolic and oncology applications.

Key numbers for fiscal year ending December, 2010:
Sales: $33.6M
One year growth: (65.8%)
Net income: ($68.8)M

Officers:
Chairman, President, and CEO: Steven B. Engle
VP Operations: Robert S. (Rob) Tenerowicz
VP Finance and CFO: Fred Kurland

Competitors:
MedImmune
Novartis
Regeneron Pharmaceuticals

Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
 
 

 

Copyrights:

Hoover's Company Profiles. © 2012 Hoover's, Inc. All rights reserved.  Read more
Quote, Chart and News. Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges). RT Realtime, DL+ Realtime BATS, EOD End Of Day, PD Previous Day. Halted. Market Data powered by QuoteMedia, fundamentals by Morningstar. Terms of use Read more

Follow us
Facebook Twitter
YouTube